Friday 15 December 2017
Contact US    |    Archive
PR
3 months ago

Quest Diagnostics Responds to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests

SECAUCUS, N.J., Sept. 22, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world s leading pr

Read on the original site


Sugar rates steady

- Uniindia
Hashtags:   

Quest

 | 

Diagnostics

 | 

Responds

 | 

Proposed

 | 

PAMA

 | 

2018

 | 

Medicare

 | 

Payment

 | 

Rates

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries